FDA
label_change
· 2021-06-16
FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)
Summary
FDA approves Zelapar (selegiline hydrochloride) supplemental application to update the product labeling. The change relates to the labeling for this Parkinson d…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZELAPAR (SELEGILINE HYDROCHLORIDE)